A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting
- PMID: 24083140
- PMCID: PMC3783672
- DOI: 10.4103/2229-516X.117051
A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting
Abstract
The day the wonder drugs, antibiotics, were available for cure to humans; dramatic rise of average life expectancy has been recorded compared to past. However, disease-causing microbes that have developed resistance to antibiotics are an increasing public health problem. Recently, superbug emergence was reported in some countries including India. One of the reasons quoted was misuse of antibiotics. Clinical signs and symptoms of infection often do not point towards the etiology. The dilemma occurs as diagnosis of sepsis is difficult because of nonspecificity of clinical signs and symptoms, and frequent overlapping of symptoms with other noninfectious causes of systemic inflammation. Key for improving survival rates lies in early diagnosis and treatment. Serum procalcitonin (PCT) levels measuring in sick patients during infection may be valuable in diagnosing the conditions, and its changing levels have some prognostic value too.
Keywords: Biomarkers; procalcitonin; resistance; sepsis; systemic inflammatory response syndrome.
Conflict of interest statement
Figures
Similar articles
-
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Surg Infect (Larchmt). 2013. PMID: 24274059 Review.
-
Future Research Needs on Procalcitonin-Guided Antibiotic Therapy: Identification of Future Research Needs From Comparative Effectiveness Review No. 78 [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan. Report No.: 13-EHC034-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan. Report No.: 13-EHC034-EF. PMID: 24783273 Free Books & Documents. Review.
-
[Role of Procalcitonin as a Sepsis Marker].Anasthesiol Intensivmed Notfallmed Schmerzther. 2019 Jun;54(6):424-433. doi: 10.1055/a-0569-7132. Epub 2019 Jun 18. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019. PMID: 31212333 German.
-
[Evaluation of diagnostic value of procalcitonin (PCT) as a marker of congenital infection in newborns].Przegl Lek. 2002;59 Suppl 1:46-9. Przegl Lek. 2002. PMID: 12108072 Polish.
-
The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.Acta Med Iran. 2015;53(9):562-7. Acta Med Iran. 2015. PMID: 26553084 Clinical Trial.
Cited by
-
In Situ Growth of CuWO4 Nanospheres over Graphene Oxide for Photoelectrochemical (PEC) Immunosensing of Clinical Biomarker.Sensors (Basel). 2019 Dec 25;20(1):148. doi: 10.3390/s20010148. Sensors (Basel). 2019. PMID: 31881686 Free PMC article.
-
Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children.BMC Pulm Med. 2021 Nov 26;21(1):386. doi: 10.1186/s12890-021-01756-4. BMC Pulm Med. 2021. PMID: 34836530 Free PMC article.
-
Biomarkers for sepsis: a review with special attention to India.Biomed Res Int. 2014;2014:264351. doi: 10.1155/2014/264351. Epub 2014 Mar 19. Biomed Res Int. 2014. PMID: 24772418 Free PMC article. Review.
-
Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease-A Meta-Analysis.PLoS One. 2015 Jun 8;10(6):e0128993. doi: 10.1371/journal.pone.0128993. eCollection 2015. PLoS One. 2015. PMID: 26053385 Free PMC article.
-
One-step-immunoassay of procalcitonin enables rapid and accurate diagnosis of bacterial infection.RSC Adv. 2021 Jun 17;11(35):21375-21383. doi: 10.1039/d1ra02494a. eCollection 2021 Jun 15. RSC Adv. 2021. PMID: 35478797 Free PMC article.
References
-
- Kristopher AM, Nikola AB. Procalcitonin: Clinical utility in diagnosing sepsis. Clin Lab News. 2009;37:76–8.
-
- Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–55. - PubMed
-
- Povoa P. C-reactive protein: A valuable marker of sepsis. Intensive Care Med. 2002;28:235–43. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous